Sinha; Seema
Patent Applications and Registrations
Patent applications and USPTO patent grants for Sinha; Seema.The latest application filed is for "novel thyroid peroxidase autoantibody immunoassay".
- Sinha; Seema - Rancho Santa Margarita CA
| Patent | Date |
|---|---|
| Novel Thyroid Peroxidase Autoantibody Immunoassay App 20220236259 - Cortese; Kayla ; et al. | 2022-07-28 |
| Thyroid peroxidase autoantibody immunoassay Grant 11,327,074 - Cortese , et al. May 10, 2 | 2022-05-10 |
| Novel Thyroid Peroxidase Autoantibody Immunoassay App 20210356459 - Cortese; Kayla ; et al. | 2021-11-18 |
| Storage Solution Compositions For The Stabilization Of Purified Mullerian Inhibiting Substance (mis) And Methods Of Use And Production Related Thereto App 20210212311 - Chuan; Tom ; et al. | 2021-07-15 |
| Non-recombinant Human Insulin-like Growth Factor Binding Protein Concentrate App 20210072266 - Lin; Spencer ; et al. | 2021-03-11 |
| Non-recombinant Human Insulin-like Growth Factor Binding Protein Concentrate App 20190018025 - Lin; Spencer ; et al. | 2019-01-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 